Skip to main content
2025 Vascular Annual Meeting Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Ticketed Event
Ticketed Event
Education Session@@@CME

C04: Who Should Not Undergo Endovascular Treatment (for CLTI)

Wednesday, June 4, 2025
3:15 PM – 4:45 PM CT
Location: Morial CC, Second Floor, Room 220-222

    Moderator(s)

  • Matthew Menard, MD

    Professor of Surgery
    Division of Vascular and Endovascular Surgery, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
    Lincoln, Massachusetts

  • Peter Schneider, MD

    Professor of Surgery
    Division of Vascular and Endovascular Surgery, University of California, San Francisco, San Francisco, CA, USA
    San Francisco, California

  • Rafael Santini Dominguez, MD (he/him/his)

    St Luke's Medical Center, Ponce Health and Sciences University, Ponce Puerto Rico, Puerto Rico

Presentations:

  • 3:15 PM – 3:20 PM CT
    Introduction

    Speaker: Matthew T. Menard, MD – Division of Vascular and Endovascular Surgery, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA

  • 3:20 PM – 3:30 PM CT
    A Critical Review of Limitations of Endovascular RTC Evidence for CLTI, including the Impact of GLASS in Life-BTK Trial Outcomes

    Speaker: Brian G. DeRubertis, MD – Weill Cornell Medicine, Division of Vascular & Endovascular Surgery

  • 3:30 PM – 3:40 PM CT
    How Do Secondary Subset Analyses from BEST-CLI Inform Which Patients are Better Served by Initial Open Surgery vs. Endovascular Therapy?

    Speaker: Olamide Alabi, MD

  • 3:40 PM – 3:50 PM CT
    How Do Specific Anatomic Patterns of Disease Impact the Choice of Endo vs. Surgery First?

    Speaker: Katharine L. McGinigle, MD – University of North Carolina at Chapel Hill

  • 3:50 PM – 4:00 PM CT
    What Constitutes 'Suitability for Open Surgical Bypass', What Percentage of CLTI Patients Have Acceptable Risk and Suitable Vein?

    Speaker: Elizabeth King-Paulson, MD

  • 4:00 PM – 4:10 PM CT
    How Does My 30 Years of Endovascular Expertise Influence My Answer to the Question of Who Should Not Have an Endovascular Approach as a First Step?

    Speaker: Peter A. Schneider, MD – Division of Vascular and Endovascular Surgery, University of California, San Francisco, San Francisco, CA, USA

  • 4:10 PM – 4:20 PM CT
    How Do WIFI and GLASS Inform our Decision-Making About Who Should Not be Treated with Endovascular as a First Approach?

    Speaker: Michael S. Conte, MD – Division of Vascular and Endovascular Surgery, University of California, San Francisco, San Francisco, CA, USA

  • 4:20 PM – 4:45 PM CT
    Panel Discussion